Bio-Techne (TECH) Net Income towards Common Stockholders (2009 - 2026)

Bio-Techne has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $54.6 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 179.36% year-over-year to $54.6 million in Q2 2026; TTM through Jun 2026 was $181.9 million, a 717.43% increase from a year earlier, with the FY2026 full-year figure at $181.9 million, up 717.43% from the prior year.
• Net Income towards Common Stockholders was $54.6 million for Q2 2026 at Bio-Techne, up from $51.0 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $89.7 million in Q3 2022, with the low at -$68.8 million in Q2 2025.
• Average Net Income towards Common Stockholders over 5 years is $39.4 million, with a median of $47.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders surged 563.12% in 2022, then tumbled 16219.44% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at $50.0 million in 2022, then plunged by 45.08% to $27.5 million in 2023, then climbed by 27.03% to $34.9 million in 2024, then climbed by 8.94% to $38.0 million in 2025, then jumped by 43.71% to $54.6 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $54.6 million (Q2 2026), $51.0 million (Q1 2026), and $38.0 million (Q4 2025), per Business Quant data.